Literature DB >> 12147648

Tissue microarrays for predictive molecular pathology.

G Sauter, M Mirlacher.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 12147648      PMCID: PMC1769731          DOI: 10.1136/jcp.55.8.575

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  9 in total

1.  Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.

Authors:  H Joensuu; P J Roberts; M Sarlomo-Rikala; L C Andersson; P Tervahartiala; D Tuveson; S Silberman; R Capdeville; S Dimitrijevic; B Druker; G D Demetri
Journal:  N Engl J Med       Date:  2001-04-05       Impact factor: 91.245

Review 2.  Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies.

Authors:  L Bubendorf; A Nocito; H Moch; G Sauter
Journal:  J Pathol       Date:  2001-09       Impact factor: 7.996

3.  Tissue microarrays: a new approach for quality control in immunohistochemistry.

Authors:  J Packeisen; H Buerger; R Krech; W Boecker
Journal:  J Clin Pathol       Date:  2002-08       Impact factor: 3.411

4.  Reliability of the tissue microarray based FISH for evaluation of the HER-2 oncogene in breast carcinoma.

Authors:  D Gancberg; A Di Leo; G Rouas; T Järvinen; A Verhest; J Isola; M J Piccart; D Larsimont
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

5.  Tissue microarrays for rapid linking of molecular changes to clinical endpoints.

Authors:  J Torhorst; C Bucher; J Kononen; P Haas; M Zuber; O R Köchli; F Mross; H Dieterich; H Moch; M Mihatsch; O P Kallioniemi; G Sauter
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

6.  Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer.

Authors:  R Simon; A Nocito; T Hübscher; C Bucher; J Torhorst; P Schraml; L Bubendorf; M M Mihatsch; H Moch; K Wilber; A Schötzau; J Kononen; G Sauter
Journal:  J Natl Cancer Inst       Date:  2001-08-01       Impact factor: 13.506

7.  High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer.

Authors:  R Simon; J Richter; U Wagner; A Fijan; J Bruderer; U Schmid; D Ackermann; R Maurer; G Alund; H Knönagel; M Rist; K Wilber; M Anabitarte; F Hering; T Hardmeier; A Schönenberger; R Flury; P Jäger; J L Fehr; P Schraml; H Moch; M J Mihatsch; T Gasser; G Sauter
Journal:  Cancer Res       Date:  2001-06-01       Impact factor: 12.701

8.  Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment.

Authors:  M D Pegram; A Lipton; D F Hayes; B L Weber; J M Baselga; D Tripathy; D Baly; S A Baughman; T Twaddell; J A Glaspy; D J Slamon
Journal:  J Clin Oncol       Date:  1998-08       Impact factor: 44.544

9.  Tissue microarrays for high-throughput molecular profiling of tumor specimens.

Authors:  J Kononen; L Bubendorf; A Kallioniemi; M Bärlund; P Schraml; S Leighton; J Torhorst; M J Mihatsch; G Sauter; O P Kallioniemi
Journal:  Nat Med       Date:  1998-07       Impact factor: 53.440

  9 in total
  13 in total

Review 1.  Demystified...tissue microarray technology.

Authors:  J Packeisen; E Korsching; H Herbst; W Boecker; H Buerger
Journal:  Mol Pathol       Date:  2003-08

2.  Ontology-based annotation and query of tissue microarray data.

Authors:  Nigam H Shah; Daniel L Rubin; Kaustubh S Supekar; Mark A Musen
Journal:  AMIA Annu Symp Proc       Date:  2006

3.  [Virtual microscopy in systems pathology].

Authors:  N Grabe
Journal:  Pathologe       Date:  2008-11       Impact factor: 1.011

4.  Factors influencing the degradation of archival formalin-fixed paraffin-embedded tissue sections.

Authors:  Ran Xie; Joon-Yong Chung; Kris Ylaya; Reginald L Williams; Natalie Guerrero; Nathan Nakatsuka; Cortessia Badie; Stephen M Hewitt
Journal:  J Histochem Cytochem       Date:  2011-02-10       Impact factor: 2.479

5.  Cell and tissue microarray technologies for protein and nucleic acid expression profiling.

Authors:  Marina Cardano; Giuseppe R Diaferia; Maurizio Falavigna; Chiara C Spinelli; Fausto Sessa; Pasquale DeBlasio; Ida Biunno
Journal:  J Histochem Cytochem       Date:  2012-11-19       Impact factor: 2.479

6.  HER2 in gastric cancer: an immunohistochemical study on tissue microarrays and the corresponding whole-tissue sections with a supplemental fish study.

Authors:  Gorana Gasljevic; Janez Lamovec; Juan Antonio Contreras; Vesna Zadnik; Mateja Blas; Slavko Gasparov
Journal:  Pathol Oncol Res       Date:  2013-06-26       Impact factor: 3.201

7.  Tissue microarray of head and neck squamous carcinoma: validation of the methodology for the study of cutaneous fatty acid-binding protein, vascular endothelial growth factor, involucrin and Ki-67.

Authors:  Wafaey Gomaa; Youqiang Ke; Hiroshi Fujii; Timothy Helliwell
Journal:  Virchows Arch       Date:  2005-10-19       Impact factor: 4.064

8.  Toward Improving Practices for Submission of Diagnostic Tissue Blocks for National Cancer Institute Clinical Trials.

Authors:  Hala Makhlouf; Mark A Watson; Heather A Lankes; Carol Weil; Maura Dickler; Michael Birrer; Christopher Moskaluk; Nilsa C Ramirez; Nader Okby; Edgar Alonsozana; Mark Barnes; Edward B Goldman; Rebecca Enos; Irina Lubensky
Journal:  Am J Clin Pathol       Date:  2020-01-02       Impact factor: 2.493

9.  Clinicopathological significance of MMP-7, laminin γ2 and EGFR expression at the invasive front of gastric carcinoma.

Authors:  Kazuhiro Sentani; Miho Matsuda; Naohide Oue; Naohiro Uraoka; Yutaka Naito; Naoya Sakamoto; Wataru Yasui
Journal:  Gastric Cancer       Date:  2013-09-19       Impact factor: 7.370

10.  Nuclear Receptor Interaction Protein (NRIP) expression assay using human tissue microarray and immunohistochemistry technology confirming nuclear localization.

Authors:  Chih-Ping Han; Ming-Yung Lee; Shu-Ling Tzeng; Chung-Chin Yao; Po-Hui Wang; Ya-Wen Cheng; Show-Li Chen; Teresa S Wu; Yeu-Sheng Tyan; Lai-Fong Kok
Journal:  J Exp Clin Cancer Res       Date:  2008-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.